If they present with fatigue, brain fog, or metabolic concerns, NAD+ or Semax is the more targeted starting point
Effects of Glucagon-Like Peptide-1 Receptor Agonists (Mono and Combination Therapy) on Energy Expenditure: A Scoping Review
Patients without serious contraindications such as active cancer or untreated endocrine disorders your provider will assess suitability during consultation
Sleep improvements are usually felt within the first few weeks
Co-administration of MP-10 and haloperidol studies revealed that even modest D 2 antagonism profoundly altered the functional impact of PDE10A inhibition, exaggerating striatal activation at intermediate doses while abolishing these effects at higher exposures
Effects on blood sugar, blood pressure and cholesterol Clinical trial data suggests several benefits of taking the treatment for obesity or type 2 diabetes: Meaningful weight loss - participants taking higher doses in trials lost a significant amount of their starting body weight on average